Management Team

Christopher Ting

DR. CHRISTOPHER TING

GROUP MD/CEO
  • Co-founder of Biomark and CEO of Innovative Diagnostics
  • Founder of Quantum Diagnostics
  • Former CEO of Quest Laboratories and Gribbles Pathology
  • Previously Assistant Head (Biomedical Sciences Group) at the Economic Development Board of Singapore
  • Member in Malaysia’s National Key Economic Area (NKEA) Healthcare initiative
Nabil_edited_edited_edited

NABIL FAWZI

GROUP DEPUTY CEO / CFO
  • Over 18 years of corporate experience including 8 years of Corporate Finance and Mergers & Acquisitions expertise
  • Previously led EY Asia Pacific’s healthcare CF/M&A space
  • Also served with PwC Singapore and UEM Group, a subsidiary of Khazanah Nasional
Rajkumar_edited_edited

RAJKUMAR RENGARAJU

GROUP COO
  • More than 18 years of experience in the medical laboratory industry
  • Spearheaded multiple quality initiatives including CAP and ISO 15189 accreditation; and Westgard Verification
  • Led and managed multiple mergers and laboratory rollout’s
ChrisSkennerton_edited_edited_edited_edited

CHRIS SKENNERTON

Group CTO
  • 30 years in digital innovation and transformation, operations, software engineering and lab information systems
  • Previously with 4Cyte Pathology, Healius, GE Healthcare and Royal Australian Air Force
(Martin) GBHSE-54_edited

MARTIN GIDDY

GROUP PMO
  • Has over 30 years of experience in medical laboratory operations, in university teaching hospitals and private laboratories
  • Previously CEO of Quantum Diagnostics and GM of Gribbles 
  • Managed the implementation of NATA and Standard Malaysia’s ISO 17025 and ISO 15189 accreditations for Gribbles Pathology